News for 'Sun Pharma'

'Biggest Single Danger Is If Remittances Come Down'

'Biggest Single Danger Is If Remittances Come Down'

Rediff.com13 May 2026

'At the first sign of real trouble, that money will move. There will be a run.'

Stock Markets Today: Sensex, Nifty50 Dive as Oil Prices Surge, Foreign Funds Exit

Stock Markets Today: Sensex, Nifty50 Dive as Oil Prices Surge, Foreign Funds Exit

Rediff.com24 Apr 2026

Indian benchmark indices Sensex and Nifty experienced a significant tumble in early trade, driven by surging global oil prices, continuous outflows by Foreign Institutional Investors (FIIs), and persistent geopolitical uncertainties, particularly in West Asia.

Agilisium invests in AI to transform pharma, biotech and medical tech companies

Agilisium invests in AI to transform pharma, biotech and medical tech companies

Rediff.com18 Mar 2026

Agilisium has invested Rs 50 crore to help pharmaceutical, biotech, and medical technology companies operationalise artificial intelligence, introducing a new professional standard called Forward Deployment Experts (FDX).

Stock Markets Today: Sensex, Nifty50 React to Global Cues as US-Iran peace talks fail

Stock Markets Today: Sensex, Nifty50 React to Global Cues as US-Iran peace talks fail

Rediff.com13 Apr 2026

Equity benchmark indices Sensex and Nifty tumbled in early trade on Monday, with the 30-share BSE Sensex falling 1,613.09 points and the 50-share NSE Nifty plunging 495 points, as the failure of US-Iran negotiations heightened concerns of a prolonged conflict driving crude oil prices sharply higher. Track Sensex, Nifty50 movement and key market drivers for April 13, 2026.

Oil Price Surge, FII Outflows Drag Indian Stock Markets Lower

Oil Price Surge, FII Outflows Drag Indian Stock Markets Lower

Rediff.com28 Apr 2026

Indian benchmark indices Sensex and Nifty experienced declines due to a sharp rally in crude oil prices, continuous foreign fund outflows, and geopolitical uncertainties. Regulatory developments in the banking sector, particularly the implementation of the Expected Credit Loss (ECL) framework, also contributed to the selling pressure.

Two months of West Asia war: Analysts see smallcap's outperformance continuing

Two months of West Asia war: Analysts see smallcap's outperformance continuing

Rediff.com29 Apr 2026

Despite geopolitical tensions and FII outflows, Indian small and midcap stocks have not only recovered losses but are also outperforming largecap indices, driven by attractive valuations, domestic institutional support, and a rebound in earnings.

Sensex, Nifty Extend Losses as Surging Oil Prices and IT Sell-off Hit Markets

Sensex, Nifty Extend Losses as Surging Oil Prices and IT Sell-off Hit Markets

Rediff.com24 Apr 2026

Indian equity benchmark indices Sensex and Nifty tumbled over 1 per cent for the third consecutive day, driven by a sharp rally in crude oil prices, massive selling in IT stocks, and unabated foreign fund outflows amid ongoing geopolitical tensions in the Middle East.

JPMorgan downgrades Indian equities to 'neutral'

JPMorgan downgrades Indian equities to 'neutral'

Rediff.com25 Apr 2026

JPMorgan has downgraded Indian equities to 'neutral' from 'overweight', citing elevated valuations, rising earnings risks, and limited exposure to next-generation technology like AI. The brokerage believes other emerging markets offer more attractive risk/reward propositions despite India's strong structural growth story.

Indian Markets Extend Losses as Crude Oil Breaches $100 Amid US-Iran Standoff

Indian Markets Extend Losses as Crude Oil Breaches $100 Amid US-Iran Standoff

Rediff.com23 Apr 2026

Indian stock markets experienced a second consecutive day of losses, with the Sensex tumbling 852 points, as crude oil prices surpassed USD 100 per barrel due to stalled US-Iran negotiations and escalating geopolitical tensions in West Asia.

Stock Markets Today: Sensex, Nifty50 Tumble as Brent Crude Breaches $100

Stock Markets Today: Sensex, Nifty50 Tumble as Brent Crude Breaches $100

Rediff.com23 Apr 2026

Indian equities on Dalal Street saw volatility as global market trends and oil price hike impacted investor sentiment. Track Sensex, Nifty50 movement and key market drivers for Apr 23, 2026.

Sensex Jumps 919 Points as Financial Stocks Lead Market Rebound

Sensex Jumps 919 Points as Financial Stocks Lead Market Rebound

Rediff.com10 Apr 2026

Indian benchmark indices Sensex and Nifty surged over 1 per cent, with the Sensex jumping 918.60 points, driven by strong buying in banking and financial counters and a positive trend in global equities, fuelled by hopes of easing West Asia tensions.

Stock Markets Rally: Sensex Climbs 500 Pts Amid Easing Geopolitical Tensions

Stock Markets Rally: Sensex Climbs 500 Pts Amid Easing Geopolitical Tensions

Rediff.com17 Apr 2026

Indian benchmark indices Sensex and Nifty rallied nearly 1 per cent, driven by optimism over easing geopolitical tensions in the Middle East and fresh foreign fund inflows, with the Sensex gaining over 500 points.

Industrial credit growth may clock 9-13% in H1CY26

Industrial credit growth may clock 9-13% in H1CY26

Rediff.com20 Apr 2026

The Indian banking sector is projected to experience a steady 9-13 per cent industrial credit growth in the first half of 2026, driven by capital expenditure, infrastructure development, and sectoral demand recovery, according to a Ficci-IBA survey.

Stock Markets Today: Sensex, Nifty50 Surge on Gains in Banking Stocks

Stock Markets Today: Sensex, Nifty50 Surge on Gains in Banking Stocks

Rediff.com10 Apr 2026

Indian markets on Dalal Street rallied sharply as easing tensions in the US-Iran conflict and stable oil prices boosted sentiment. Track Nifty 50 and BSE Sensex performance and key global triggers.

Sensex and Nifty Rally as Oil Prices Drop and Global Markets Recover

Sensex and Nifty Rally as Oil Prices Drop and Global Markets Recover

Rediff.com7 Apr 2026

Indian stock market benchmarks Sensex and Nifty closed higher on Tuesday, buoyed by a drop in crude oil prices, a rally in global markets, and strong buying in IT stocks.

'FY27 Presents Clear Runway For Earnings Improvement'

'FY27 Presents Clear Runway For Earnings Improvement'

Rediff.com16 Apr 2026

'In investing, poor sentiment is always a good vintage to build a portfolio.'

Obesity Drug Can't Be Advertised Anymore

Obesity Drug Can't Be Advertised Anymore

Rediff.com12 Mar 2026

'Any promotional activity carried out under the pretext of disease awareness, influencer engagement, corporate campaigns, or similar activities that create brand recall/product visibility of the prescription shall also be treated as violations.'

Stock Market Today: Sensex, Nifty50 Dip on High Crude Price

Stock Market Today: Sensex, Nifty50 Dip on High Crude Price

Rediff.com6 Apr 2026

Indian equities on Dalal Street declined in early trade on Monday as crude oil prices climbed amid fears of further escalation in the West Asia the war. Track Sensex, Nifty50 movement and key market drivers for Apr 6, 2026.

Sensex and Nifty Recover as Crude Oil Prices Dip and Bank Stocks Rally

Sensex and Nifty Recover as Crude Oil Prices Dip and Bank Stocks Rally

Rediff.com6 Apr 2026

Indian benchmark indices Sensex and Nifty rebounded sharply on Monday, driven by a correction in crude oil prices due to ceasefire efforts in West Asia and strong buying in bank stocks.

AI is fast becoming central to how drugs will be discovered

AI is fast becoming central to how drugs will be discovered

Rediff.com25 Feb 2026

Artificial intelligence (AI) is no longer a side conversation for Indian pharma. It is fast becoming central to how drugs will be discovered, made, and supplied. Along with that shift comes a sharper focus on innovation, on the one hand, and quality and trust, on the other.

Sensex and Nifty Rally as US-Iran Ceasefire Boosts Global Markets

Sensex and Nifty Rally as US-Iran Ceasefire Boosts Global Markets

Rediff.com8 Apr 2026

Indian stock markets experienced a significant rally following the announcement of a US-Iran ceasefire, coupled with a drop in crude oil prices. The Sensex and Nifty both closed nearly 4 per cent higher, mirroring gains in global markets.

Seniors to Drive 25% of India's Pharma

Seniors to Drive 25% of India's Pharma

Rediff.com21 Nov 2025

'Once the 60-plus population hits 20 to 30 per cent of the country, the demand for elderly-care treatments will surge -- cardiac, metabolic, neurological, and musculoskeletal medicines are going to dominate the market for the next several decades.'

India Inc Salary Hikes Hold Steady

India Inc Salary Hikes Hold Steady

Rediff.com7 Apr 2026

'Decisions on talent and rewards have shifted as employees and companies are operating in a buyer's market across most skill categories.'

Stock Market Today: Sensex, Nifty50 Surge as US-Iran Tensions Ease

Stock Market Today: Sensex, Nifty50 Surge as US-Iran Tensions Ease

Rediff.com1 Apr 2026

Indian markets on Dalal Street rallied sharply as easing tensions in the US-Iran conflict and stable oil prices boosted sentiment. Track Nifty 50 and BSE Sensex performance and key global triggers.

Mumbai businesswoman stripped, filmed at gunpoint in pharma firm office

Mumbai businesswoman stripped, filmed at gunpoint in pharma firm office

Rediff.com1 Dec 2025

As per the FIR, the woman was called to the company's office, where she was allegedly assaulted and stripped.

Abbott Bets On Semaglutide Boom

Abbott Bets On Semaglutide Boom

Rediff.com28 Feb 2026

Abbott will exclusively distribute and market Extensior in the country, becoming the second company to secure sole distribution rights for Novo's semaglutide portfolio in India, after Emcure Pharma.

Nomura, Citi slash year-end Nifty 50 target

Nomura, Citi slash year-end Nifty 50 target

Rediff.com17 Mar 2026

Foreign brokerages have started to cut their year-end targets for the Nifty 50 index amid the ongoing West Asia conflict.

Gulf War: Stocks That Tanked The Most

Gulf War: Stocks That Tanked The Most

Rediff.com14 Apr 2026

West Asia conflict triggers sharp sell-off in Indian markets, with realty, banking and auto stocks leading losses amid energy shock fears.

The Rediff Podcast: Stay Invested When Markets Fall: Swati Khemani

The Rediff Podcast: Stay Invested When Markets Fall: Swati Khemani

Rediff.com2 Apr 2026

'Portfolios built in these phases often deliver the strongest outcomes over time.'

Cough Syrup Deaths: This Is Sresan Pharma Owner

Cough Syrup Deaths: This Is Sresan Pharma Owner

Rediff.com11 Oct 2025

In a major development in the toxic syrup tragedy that killed 23 children in Madhya Pradesh, S Ranganathan, director of the Tamil Nadu-based Sresan Pharmaceuticals, has been arrested and remanded to 10 days' police custody.

Indian pharma companies see sharp drop in adverse USFDA findings in 2025

Indian pharma companies see sharp drop in adverse USFDA findings in 2025

Rediff.com8 Jan 2026

The US Food and Drug Administration (USFDA) recorded a significant decline in serious regulatory findings at Indian drug manufacturing facilities between January and December 2025. Data reveals that 'official action indicated' (OAI) cases - the most severe classification - nearly halved over the past year.

Why Shiv Sena MP Milind Deora Is Against Weight-Loss Drugs

Why Shiv Sena MP Milind Deora Is Against Weight-Loss Drugs

Rediff.com9 Apr 2026

'The unregulated marketing has to stop. People are getting recommendations for this from gym trainers, from marriage counsellors -- that is simply unacceptable.' ''There are many ways to lose weight -- eat less, fast, exercise, eat healthy. That is how you lose weight.'

The Rediff Podcast: Stay Invested When Markets Fall: Swati Khemani

The Rediff Podcast: Stay Invested When Markets Fall: Swati Khemani

Rediff.com1 Apr 2026

'Portfolios built in these phases often deliver the strongest outcomes over time.'

Strong therapies, JB to lift Torrent Pharma

Strong therapies, JB to lift Torrent Pharma

Rediff.com18 Nov 2025

A strong performance in the July-September quarter of 2025-26 (FY26) and expectations of growth from launches and acquisition-led synergies led to a 6.65 per cent jump in the share price of Torrent Pharmaceuticals.

Stock Market Today Feb 27, 2026 ' Sensex tanks 961 points, Nifty50 Fall 1.25%

Stock Market Today Feb 27, 2026 ' Sensex tanks 961 points, Nifty50 Fall 1.25%

Rediff.com27 Feb 2026

Benchmark indices Sensex and Nifty experienced a significant decline, falling over 1 per cent due to foreign fund outflows and global uncertainties.

'Quality Companies To Lead Next IPO Wave'

'Quality Companies To Lead Next IPO Wave'

Rediff.com13 Mar 2026

'The next phase of India's IPO cycle will be defined by quality, pricing discipline and investor selectivity.'

Stock markets extend winning run to 3rd day; Sensex, Nifty climb nearly 1%

Stock markets extend winning run to 3rd day; Sensex, Nifty climb nearly 1%

Rediff.com18 Mar 2026

Indian stock market indices Sensex and Nifty closed nearly 1 per cent higher, marking their third consecutive day of gains, supported by a slight decrease in crude oil prices and positive global market trends.

India-EU FTA: Textiles, pharma, engineering to get major boost

India-EU FTA: Textiles, pharma, engineering to get major boost

Rediff.com26 Jan 2026

Textiles, pharmaceuticals, chemicals, engineering goods, gems and jewellery exports will receive a boost from the free trade agreement between India and the 27-nation European Union, according to exporters.

Pharma stocks slide as US headwinds hurt

Pharma stocks slide as US headwinds hurt

Rediff.com16 Sep 2025

Concerns over weakening demand for Indian pharmaceutical (pharma) drugs in the US - their largest export market - have weighed heavily on investor sentiment this year. While the Nifty 50 has gained 6.02 per cent year - to - date (as on September 15), the Nifty Pharma index has declined 5.18 per cent, National Stock Exchange data shows.

Sensex jumps 938 pts, Nifty settles above 23,400 on bargain buying

Sensex jumps 938 pts, Nifty settles above 23,400 on bargain buying

Rediff.com16 Mar 2026

Indian stock market benchmarks Sensex and Nifty rebounded by over 1% on Monday, driven by value-buying in banking stocks after a three-day slump. Key gainers included UltraTech Cement, HDFC Bank, and Mahindra & Mahindra.